Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
- Conditions
- Inflammatory Bowel Diseases
- Interventions
- Other: Nutrition specialistDietary Supplement: Ensure Surgery Immunonutrition shakes
- Registration Number
- NCT06309017
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Able and willing to provide written informed consent
- Aged 18 years of age or older
- Confirmed diagnosis of inflammatory bowel disease
- Scheduled for disease-related intestinal resection at NYU Langone Health
- No current diagnosis of inflammatory bowel disease
- Age less than 18
- Not proficient (able to read and answer questions) in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Nutrition specialist Nutrition specialist Participants will be assigned to this arm if the subject is determined malnourished. They will be sent to a nutrition specialist for a nutrition focused visit and will be provided standard of care intervention prior surgery. Nutrition specialist Ensure Surgery Immunonutrition shakes Participants will be assigned to this arm if the subject is determined malnourished. They will be sent to a nutrition specialist for a nutrition focused visit and will be provided standard of care intervention prior surgery. Standard of Care Ensure Surgery Immunonutrition shakes Participants that show no signs of malnutrition will be assigned to this arm. The subject will be provided with education and schedule of Ensure® Surgery Immunonutrition shakes for prior to surgery as per standard of care.
- Primary Outcome Measures
Name Time Method Length of hospital stay Up to 30 days post-surgery From the time the patient is admitted at hospital for surgery until the patient is discharged.
Proportion of patients who experienced postoperative major complications Visit 3 (30 days post-surgery) Major complications include infection, bleeding (requiring blood transfusion or requiring intervention), cardiac event (myocardial infarction, arrhythmia, and cardiac arrest), stroke, acute kidney injury (increase in serum creatinine of ≥0.3 mg/dL from baseline or ≥1.5 times baseline), venous thromboembolism, reoperation, readmission, and need for ICU-level care. The outcome measure will be obtained from the electronic health record (EHR).
- Secondary Outcome Measures
Name Time Method Proportion of patients with 30 day readmission Up to 30 days post-surgery Proportion of patients who participated in a nutritional intervention program after surgery Visit 3 (30 days post-surgery) Number of nutritional shakes completed Visit 3 (30 days post-surgery) Proportion of patients who participated in a nutritional intervention program before surgery Visit 3 (30 days post-surgery) Percentage of nutritional shakes completed overall Visit 3 (30 days post-surgery) Percentage of nutritional shakes completed pre-surgery One day prior to surgery Subject will be called the day prior to surgery to determine the number of shakes consumed by patient.
Proportion of patients who experienced any postoperative complications Visit 3 (30 days post-surgery) Percentage of nutritional shakes completed post-surgery One week post surgery One week after surgery, a phone call will follow to determine how many shakes subject consumed.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States